SCHEMBL2885680

SCHEMBL2885680

OCc1cccnc1Oc1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.73
MEN1 O00255 2/20 0.73
ALDH1A1 P00352 3/20 0.53
MAPK8 P45983 3/20 0.51
TDP1 Q9NUW8 1/20 0.50
HTR1A P08908 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
LTA4H P09960 1/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
HTT P42858 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
ELANE P08246 1/20 0.43
KDM4E B2RXH2 1/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2893836 0.85 KMT2A (0.72) KMT2AMEN1L3MBTL1CYP1A2CYP2C9
SCHEMBL28014857 0.85 KMT2A (0.72) KMT2AMEN1ALDH1A1MAPK8L3MBTL1
SCHEMBL7367309 0.85 MEN1 (0.63) KMT2AMEN1ALDH1A1MAPK8TDP1
SCHEMBL13990891 0.82 KMT2A (0.55) KMT2AMEN1ALDH1A1MAPK8TDP1
SCHEMBL3290447 0.82 ALDH1A1 (0.53) KMT2AMEN1ALDH1A1MAPK8TDP1
SCHEMBL20817947 0.82 KMT2A (0.51) KMT2AMEN1ALDH1A1MAPK8TDP1
SCHEMBL7370543 0.81 MEN1 (0.58) KMT2AMEN1ALDH1A1MAPK8SLC6A2
SCHEMBL2891089 0.81 MEN1 (0.58) KMT2AMEN1ALDH1A1CYP1A2CYP2C19
SCHEMBL28350785 0.81 KMT2A (0.51) KMT2AMEN1ALDH1A1MAPK8TDP1
Hydrochloric Acid SCHEMBL3562945 0.81 ALDH1A1 (0.51) KMT2AMEN1ALDH1A1MAPK8TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12435078-B2 Pyridazinones and methods of use thereof GFB (ABC), LLC (US) 2025-10-07 US disclosed
US-20230203028-A1 PYRIDAZINONES AND METHODS OF USE THEREOF GFB (ABC), LLC 2023-06-29 US disclosed
US-20230203028-A1 PYRIDAZINONES AND METHODS OF USE THEREOF GFB (ABC), LLC 2023-06-29 US disclosed
EP-3684364-A2 PYRIDAZINONES AND METHODS OF USE THEREOF Goldfinch Bio, Inc. (US) 2020-07-29 EP disclosed
WO-2019055966-A2 PYRIDAZINONES AND METHODS OF USE THEREOF GOLDFINCH BIO, INC. (US) 2019-03-21 WO disclosed
WO-2019055966-A2 PYRIDAZINONES AND METHODS OF USE THEREOF GOLDFINCH BIO, INC. (US) 2019-03-21 WO disclosed
EP-2098517-B1 NOVEL PHENYL-ISOXAZOL-3-OL DERIVATIVE MSD KK (JP) 2013-12-18 EP disclosed
US-8367708-B2 Phenyl-isoxazol-3-ol derivative MSD K.K. (JP) 2013-02-05 US disclosed
US-20100130559-A1 NOVEL PHENYL-ISOXAZOL-3-OL DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-05-27 US disclosed
EP-2098517-A1 NOVEL PHENYL-ISOXAZOL-3-OL DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2009-09-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203028-A1 PYRIDAZINONES AND METHODS OF USE THEREOF PDXK, ATP6V1B1, REN KMT2A 3397/4885MEN1 2719/4885ALDH1A1 649/4885
US-20100130559-A1 NOVEL PHENYL-ISOXAZOL-3-OL DERIVATIVE GPR119, FFAR3, FFAR2 KMT2A 1822/4885MEN1 4777/4885ALDH1A1 2105/4885
US-12435078-B2 Pyridazinones and methods of use thereof PDXK, ATP6V1B1, REN KMT2A 3397/4885MEN1 2719/4885ALDH1A1 649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.